Literature DB >> 33860369

Longitudinal structural brain changes in Friedreich ataxia depend on disease severity: the IMAGE-FRDA study.

Ian H Harding1,2, Louise A Corben3,4,5, Louisa P Selvadurai3, Nellie Georgiou-Karistianis6, Rosita Shishegar3,7, Cathlin Sheridan3, Gary F Egan3,1, Martin B Delatycki4,5,8.   

Abstract

BACKGROUND: Friedreich ataxia is an inherited neurodegenerative disease, with cerebral and cerebellar pathology evident. Despite an increased understanding of its neuropathology, disease progression in this disease remains poorly understood. This study aimed to characterise longitudinal change in brain structure using a multi-modal approach across cerebral and cerebellar grey and white matter.
METHODS: T1-weighted, diffusion-tensor, and magnetisation transfer magnetic resonance images were obtained from 28 individuals with Friedreich ataxia and 29 age- and gender-matched controls at two time-points, 2 years apart. Region-of-interest and exploratory between-group comparisons assessed changes in brain macrostructure (cerebellar lobule volume, cerebral cortical thickness/gyrification, brain white matter volume) and microstructure (white matter fractional anisotropy, mean/axial/radial diffusivity, magnetisation transfer ratio). Rates of change were correlated against change in neurological severity, Time 1 severity, and onset age.
RESULTS: Individuals with Friedreich ataxia had a greater rate of white matter volume loss than controls in the superior cerebellar peduncles and right peri-thalamic/posterior cerebral regions, and greater reduction in left primary motor cortex gyrification. Greater cerebellar/brainstem white matter volume loss and right dorsal premotor gyrification loss was observed amongst individuals with less severe neurological symptoms at Time 1. Conversely, cerebral atrophy and changes in axial diffusivity were observed in individuals with more severe Time 1 symptoms. Progression in radial diffusivity was more pronounced amongst individuals with earlier disease onset. Greater right ventral premotor gyrification loss correlated with greater neurological progression.
CONCLUSION: Heterogeneity in Friedreich ataxia progression is observed at the neurobiological level, with evidence of earlier cerebellar and later cerebral degeneration.

Entities:  

Keywords:  Cortical morphometry; Diffusion tensor imaging (DTI); Friedreich ataxia; Longitudinal neuroimaging; Magnetic resonance imaging (MRI); Tensor-based morphometry (TBM)

Year:  2021        PMID: 33860369     DOI: 10.1007/s00415-021-10512-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  47 in total

1.  Delayed-onset Friedreich's ataxia revisited.

Authors:  Claire Lecocq; Perrine Charles; Jean-Philippe Azulay; Wassilios Meissner; Myriam Rai; Karine N'Guyen; Yann Péréon; Nelly Fabre; Elsa Robin; Sylvie Courtois; Lucie Guyant-Maréchal; Fabien Zagnoli; Gabrielle Rudolf; Mathilde Renaud; Mathieu Sévin-Allouet; Fabien Lesne; Nick Alaerts; Cyril Goizet; Patrick Calvas; Alexandre Eusebio; Claire Guissart; Pascal Derkinderen; Francois Tison; Alexis Brice; Michel Koenig; Massimo Pandolfo; Christine Tranchant; Alexandra Dürr; Mathieu Anheim
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

2.  Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.

Authors:  S H Subramony; W May; D Lynch; C Gomez; K Fischbeck; M Hallett; P Taylor; R Wilson; T Ashizawa
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

3.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.

Authors:  V Campuzano; L Montermini; Y Lutz; L Cova; C Hindelang; S Jiralerspong; Y Trottier; S J Kish; B Faucheux; P Trouillas; F J Authier; A Dürr; J L Mandel; A Vescovi; M Pandolfo; M Koenig
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

4.  Clinical and genetic study of Friedreich ataxia in an Australian population.

Authors:  M B Delatycki; D B Paris; R J Gardner; G A Nicholson; N Nassif; E Storey; J C MacMillan; V Collins; R Williamson; S M Forrest
Journal:  Am J Med Genet       Date:  1999-11-19

5.  A study of up to 12 years of follow-up of Friedreich ataxia utilising four measurement tools.

Authors:  Geneieve Tai; Louise A Corben; Lyle Gurrin; Eppie M Yiu; Andrew Churchyard; Michael Fahey; Brian Hoare; Sharon Downie; Martin B Delatycki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-11       Impact factor: 10.154

6.  Scale for the assessment and rating of ataxia: development of a new clinical scale.

Authors:  T Schmitz-Hübsch; S Tezenas du Montcel; L Baliko; J Berciano; S Boesch; C Depondt; P Giunti; C Globas; J Infante; J-S Kang; B Kremer; C Mariotti; B Melegh; M Pandolfo; M Rakowicz; P Ribai; R Rola; L Schöls; S Szymanski; B P van de Warrenburg; A Dürr; T Klockgether; Roberto Fancellu
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

Review 7.  Clinical features of Friedreich ataxia.

Authors:  Martin B Delatycki; Louise A Corben
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

8.  Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

Authors:  Lisa S Friedman; Jennifer M Farmer; Susan Perlman; George Wilmot; Christopher M Gomez; Khalaf O Bushara; Katherine D Mathews; S H Subramony; Tetsuo Ashizawa; Laura J Balcer; Robert B Wilson; David R Lynch
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

9.  Progression of Friedreich ataxia: quantitative characterization over 5 years.

Authors:  Maya Patel; Charles J Isaacs; Lauren Seyer; Karlla Brigatti; Sarah Gelbard; Cassandra Strawser; Debbie Foerster; Julianna Shinnick; Kimberly Schadt; Eppie M Yiu; Martin B Delatycki; Susan Perlman; George R Wilmot; Theresa Zesiewicz; Katherine Mathews; Christopher M Gomez; Grace Yoon; Sub H Subramony; Alicia Brocht; Jennifer Farmer; David R Lynch
Journal:  Ann Clin Transl Neurol       Date:  2016-07-25       Impact factor: 4.511

10.  Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.

Authors:  V Campuzano; L Montermini; M D Moltò; L Pianese; M Cossée; F Cavalcanti; E Monros; F Rodius; F Duclos; A Monticelli; F Zara; J Cañizares; H Koutnikova; S I Bidichandani; C Gellera; A Brice; P Trouillas; G De Michele; A Filla; R De Frutos; F Palau; P I Patel; S Di Donato; J L Mandel; S Cocozza; M Koenig; M Pandolfo
Journal:  Science       Date:  1996-03-08       Impact factor: 47.728

View more
  1 in total

Review 1.  Recessive cerebellar and afferent ataxias - clinical challenges and future directions.

Authors:  Marie Beaudin; Mario Manto; Jeremy D Schmahmann; Massimo Pandolfo; Nicolas Dupre
Journal:  Nat Rev Neurol       Date:  2022-03-24       Impact factor: 42.937

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.